Market closedNon-fractional
GlaxoSmithKline/GSK
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About GlaxoSmithKline
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Ticker
GSK
Sector
Healthcare
Trading on
LSE
Industry
Pharmaceuticals
Headquarters
Brentford, United Kingdom
Employees
70,212
Website
www.gsk.com
GlaxoSmithKline Metrics
BasicAdvanced
£62B
Market cap
14.00
P/E ratio
£1.09
EPS
0.27
Beta
£0.59
Dividend rate
3.87%
Dividend yield
Price and volume
Market cap
£62B
Beta
0.27
Dividend rate
£0.59
Financial strength
Current ratio
0.867
Quick ratio
0.574
Long term debt to equity
114.566
Total debt to equity
134.341
Dividend payout ratio (TTM)
50.40%
Interest coverage (TTM)
12.93%
Management effectiveness
Return on assets (TTM)
9.32%
Return on equity (TTM)
38.78%
Valuation
Price to earnings (TTM)
13.995
Price to revenue (TTM)
2.011
Price to book
4.49
Price to tangible book (TTM)
-7.06
Price to free cash flow (TTM)
11.6
Dividend yield (TTM)
3.87%
Growth
Revenue change (TTM)
5.69%
Earnings per share change (TTM)
-69.60%
3-year revenue growth (CAGR)
0.63%
3-year earnings per share growth (CAGR)
-5.81%
3-year dividend per share growth (CAGR)
-16.13%
What the Analysts think about GlaxoSmithKline
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GlaxoSmithKline stock.
GlaxoSmithKline Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GlaxoSmithKline Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GlaxoSmithKline News
AllArticlesVideos
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GlaxoSmithKline stock?
GlaxoSmithKline (GSK) has a market cap of £62B as of July 27, 2024.
What is the P/E ratio for GlaxoSmithKline stock?
The price to earnings (P/E) ratio for GlaxoSmithKline (GSK) stock is 14 as of July 27, 2024.
Does GlaxoSmithKline stock pay dividends?
Yes, the GlaxoSmithKline (GSK) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is £0.59 and the yield is 3.87%. GlaxoSmithKline has a payout ratio of 50.4% on a trailing twelve-month basis.
When is the next GlaxoSmithKline dividend payment date?
The next GlaxoSmithKline (GSK) dividend payment date is unconfirmed.
What is the beta indicator for GlaxoSmithKline?
GlaxoSmithKline (GSK) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell GlaxoSmithKline stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.